BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34359680)

  • 1. Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC).
    Siemert J; Wald T; Kolb M; Pettinella I; Böhm U; Pirlich M; Wiegand S; Dietz A; Wichmann G
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients.
    Wichmann G; Lehmann C; Herchenhahn C; Kolb M; Hofer M; Wiegand S; Dietz A
    Front Oncol; 2018; 8():168. PubMed ID: 29868484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma.
    Zhang Y; Gu D
    Front Oncol; 2022; 12():889844. PubMed ID: 35847918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.
    Wichmann G; Herchenhahn C; Boehm A; Mozet C; Hofer M; Fischer M; Kolb M; Dietz A
    Oral Oncol; 2017 Jun; 69():115-127. PubMed ID: 28559015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
    Yamashita T; Shimada H; Tanaka S; Araki K; Tomifuji M; Mizokami D; Tanaka N; Kamide D; Miyagawa Y; Suzuki H; Tanaka Y; Shiotani A
    Cancer Med; 2016 Mar; 5(3):415-25. PubMed ID: 26798989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.
    Gallo O; Masini E; Bianchi B; Bruschini L; Paglierani M; Franchi A
    Hum Pathol; 2002 Jul; 33(7):708-14. PubMed ID: 12196922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
    Guo YZ; Sun HH; Wang XT; Wang MT
    J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Genetic Variants in ANGPT/TEK and VEGF/VEGFR with Progression and Survival in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy or Radiochemotherapy.
    Butkiewicz D; Gdowicz-Kłosok A; Krześniak M; Rutkowski T; Krzywon A; Cortez AJ; Domińczyk I; Składowski K
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32526933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Levels of Stromal Cell-Derived Factor-1α and Vascular Endothelial Growth Factor Predict Clinical Outcomes in Head and Neck Squamous Cell Carcinoma Patients Receiving TPF Induction Chemotherapy.
    Chen YH; Chien CY; Wang YM; Li SH
    Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
    Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
    Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
    Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
    J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma.
    Wichmann G; Pavlychenko M; Willner M; Halama D; Kuhnt T; Kluge R; Gradistanac T; Fest S; Wald T; Lethaus B; Dietz A; Wiegand S; Zebralla V
    Front Oncol; 2021; 11():737080. PubMed ID: 34868927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of cyfra 21-1, a tumor marker, in head and neck squamous cell carcinoma.
    Céruse P; Rabilloud M; Charrié A; Dubreuil C; Disant F
    Ann Otol Rhinol Laryngol; 2005 Oct; 114(10):768-76. PubMed ID: 16285267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.